Followers | 150 |
Posts | 9,319 |
Boards Moderated | 7 |
Alias Born | 03/29/2017 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Flair is the man.. I always say treat your body like an amusement park lol. $QSIM looking great, news look fantastic.
QSIM news: LAS VEGAS, NV -- (Marketwired) -- 11/06/17 -- Vivakor, Inc. (OTC PINK: VIVK) -- VIVAVENTURES EXPLORATION LLC, A VIVAKOR COMPANY, announces the successful acquisition of a partial non-operating working interest in the CAMPBELL 1-26H23H Well with Sand Ridge Exploration and Production, LLC as the operator of the well.
VivaVentures Exploration LLC., engages in acquiring non-operating working interest oil and gas wells in the Oklahoma Scoop & Stack play located in the Anadarko Basin. The company is actively pursuing non-operating, working interest wells with various major oil and gas producers, some acquisitions may be for as many as 200 wells in Oklahoma. The CAMPBELL 1-26H23H is located in Major County, Oklahoma.
This type of acquisition is part of the Company's strategy to increase its overall hydrocarbon holdings. Vivakor's technologies can have a huge impact on increasing the raw natural resources value. VivaVentures Exploration is planning to acquire non-operating working interests in a number of wells within the leading producing counties, with the top operators in the area, and within the best land formations that will increase the Company's asset value
Anyone without tickets on this trains gonna be hating themselves when it starts up.
Why is that? Them dumping kills PPS and kills volume. They cannot cash in anymore. If PPS was allowed to rise, volume would follow. They could safely dump shares @ a higher PPS without flinching. Volume would just eat it up. How many shares they need 2 convert now, volume wont ever allow it.
I don't see that. Email back from company told me they would have signed if volume didn't pick up. They thought this would run with volume for awhile so decided to cash out now.
Beyond worthless, volume is gone now. They had a chance to make easy x5 IMO on the shares but took the dipshit route.
You know it brother. $RCHA gonna surprise this month.
LOL they are insane. They thought 2 themselves, "Hey lets finish what Irma didn't.."
Awesome day so far here in $QSIM. 16s close 2 falling!
Volume and steady rise of PPS without PRs gives good credence 2 what you saw my man. $RMRK has a power crew attached 2 it in $CRCW.
I agree EnergySaver. A lot of good potential/upside here.
Yeah Pepsi. The upside here is insane. Like you say brother, anyone holding this will be happy.
HPGN CEO was on the medical advisory board @ RCHA for quite some time before leaving 4 HPGN. HPGN is very deep with RCHA hands.
That equipment purchase and sales agreement with Vivakors(VIVK) is huge. Not only is QSIM selling patents but also reactors, equipment and inventory.
Registrant agreed to sell to Vivakor: 1. Two patents relating to the manufacture and production of nano-particles for use in conjunction with ammonia, methanol, hydrogen, light olefins and other chemical applications which may be improved through the use of FeNIX and other nano-particles; 2. Reactors related to nanomaterials production, passivation equipment, ammonia bench-test and ammonia lab analysis equipment, nanomaterials inventory, computer equipment, and related property of the Registrant related to nanomaterials and ammonia processes.
In return, the Registrant shall receive from Vivakor up to $5.0 million in Vivakor convertible Preferred Series C Shares (“the Preferred Shares”) as follows:
1. The Registrant shall receive $2.5 million in Preferred Shares upon execution of the September 2017 Agreement;
2. The Registrant shall receive an additional $2.5 million in Preferred Shares should a purchase order for a minimum of $450,000 be received for nano iron from an ammonia plant within six months of the signing of the September 2017 Agreement, or;
3. The Registrant shall receive an additional $1.5 million in Preferred Shares should a purchase order for a minimum of $450,000 be received for nano iron from an ammonia plant within six months and one day to one year of the signing of the September 2017 Agreement, or:
4. The Registrant shall receive an additional $0.5 million in Preferred Shares should a purchase order for a minimum of $450,000 be received for nano iron from an ammonia plant within one year and one day to two years of the signing of the September 2017 Agreement,
Seems like some cutting edge tech, I-cinema. Awesome $MVES grabbed Emerging Pictures. BTW that website is high quality.
I think $MVES has its eyes set higher imo.. They paid a lot of money 4 that PCAOB Member Accounting firm. They want 2 trade on OTCQB I believe.
In related news, on May 4th, 2017 OTC Markets announced that current Alternative Reporting Companies such as The Movie Studio are now eligible for the OTCQB Venture Market with the following requirements.
NEW OTCQB VENTURE MARKET MINIMUM REQUIREMENTS:
U.S. companies must have audited annual financials by a PCAOB auditor.
Minimum bid price of $0.01 per share for thirty consecutive days prior to listing
The Board of Directors must consist of two independent officers/directors
The Audit Committee must consist of two independent officers/directors
HALLANDALE BEACH, FL--(Marketwired - May 22, 2017) - The Movie Studio, Inc. ("MVES") (the "Company") (OTC PINK: MVES) www.themoviestudio.com.
The Movie Studio intends to proceed towards audited, fully reporting status as required with the filing of an S-1 Registration Statement with the SEC. As part of the process on May 17th, 2017, the Company entered into an engagement agreement with a PCAOB Member Accounting firm to audit the Company's 2015 and 2016 financial statements.
"We are taking the necessary steps to provide a higher level of transparency for our shareholders, investors and market makers as well as facilitate our executed agreement with GPL Ventures," stated Gordon Scott Venters, CEO of The Movie Studio Inc.
Pursuant to the executed Securities Purchase Agreement, the Company at its sole and exclusive option, may issue and sell to GPL shares of the Company's common stock equal to a value of up to Five Million Dollars ($5,000,000). The agreement requires that The Movie Studio file an S-1 Registration Statement and that it is deemed effective by the SEC qualifying the Company's Shares under Regulation A. Upon the S-1 Registration being deemed effective, the Company may now elect to trade on the OTCQB, OTCQX or other larger national markets subject to meeting minimum requirements.
Here is some info you might have missed. They are creating a drug 2 save lives.. Paying off debt that fulfils that mission is ok imo.
http://www.richpharmaceuticals.com/wp-content/uploads/2017/08/PR-Rich-Pharmaceuticals-Announces-Consulting-Agreement-FINAL.pdf
http://www.richpharmaceuticals.com/wp-content/uploads/2017/06/Rich-Announces-Principal-Doctor-FINAL.pdf
http://www.richpharmaceuticals.com/wp-content/uploads/2017/06/Rich-Announces-Institutional-Review-Board-Submission-FINAL.pdf
That's unfair 2 say. They are in ongoing phase 1/2 trials 4 treating AML and HL. News has been sparse but some good info out there.
It is currently in Phase 1/2 clinical trials for the treatment of AML and HL. Rich Pharmaceuticals' goal is to extend refractory patients life expectancy and increase quality of life. Rich Pharmaceuticals' primary development stage product candidate, RP-323, is being designed to treat blood and cancer related diseases through non-evasive outpatient facilities. RP-323 is a phorbol ester, which induces differentiation and/or apoptosis in multiple cell lines and primary cells, activates protein kinase C (PKC), and modulates the activity of multiple downstream cell signaling pathways, including mitogen-activated protein kinase (MAPK) pathways. RP-323 induces PKC to produce NF kappa, which then produces NF kappa B that has the ability to regulate cellular responses by entering into the nucleus of cells. NF kappa B binds to DNA and changes the nature of the cell and (1) induces differentiation; (2) induces proliferation; (3) cytokine induction; (4) and/or apoptosis
I believe this will be the major revenue maker here. Subscription based credit card service 2 access MVES library. Also how I read this, they intend 2 use the prior technology for streaming feature films 2 theaters with this new app. If certain productions allow them 2 be streamed same time as brick and mortar theaters release dates, that would be a game changer.
HALLANDALE BEACH, Fla., Oct. 19, 2017 (GLOBE NEWSWIRE) -- The Movie Studio, Inc. (OTC:MVES) (the "Company") www.TheMovieStudio.com is a vertically integrated motion picture production and distribution company motion pictures, production and distribution assets.
The Movie Studio is pleased to announce that it has successfully negotiated a content license and revenue participation agreement with Lotus Research, Inc. for the Vu-Me on-line content aggregation and application platform. The Movie Studio and Vu-Me App Platform intend to implement an on-line platform and dashboard for "The Movie Studio" with a subscription based credit card interface to access The Movie Studio library and "New Releases" of owned and licensed content available for Video on Demand (VOD) to monetize the content including a back end "bank" In addition to the VOD Platform, The Movie Studio intends to integrate in the acquisition of Emerging Pictures and all of its assets, including its proprietary intellectual property, which includes an innovative technology for a Commercial VOD (Video on Demand) digital delivery platform presently deployed in over 130 theaters, as well as digital distribution rights to potentially many hundreds of films. The technology can also be used to gauge consumer demand as well as provide advanced data analytics to match and deliver content. This enables providers and exhibitors to be more effective and advanced in their distribution tactics and have greater direct contact and feedback from their audiences. The network of over 130 theaters in which the VOD hardware is presently deployed spans 36 states in the U.S.
"With many competing apps available to consumers, Lotus Research opted to leap ahead of the technology wave with several important features," noted Leo Pimentel. These features include: (1) low latency across WiFi and cellular networks; (2) 4K and HD streaming and playback; (3) a proprietary compression algorithm; (4) rapid share-ability across social networking sites and communication channels; (5) machine-learning algorithms to refine and enhance search and content relevance; and (6) effective content tracking across all platforms on and off Vu-Me for robust and accurate reporting and metrics gathering. Leo Pimentel, CEO & Founder, stated today.
About Lotus Research, Inc.: Lotus Research is headquartered in New York City and was founded by Leo Pimentel in 2014. With a mobile-first approach, Lotus Research emphasizes advanced technology, exceptional product design, and immersive user experiences to bring practical and entertaining solutions to market.
"Vu-Me (vu.me) is The Movie Studio "APP" that we have always envisioned and when completed, could accelerate The Movie Studio content and business model with a unique platform currently not implemented by any other independent motion picture Company and create unique value propositions for on-line subscribers aligning an APP for Theatrical Releases and subsequent VOD releases, would be a "Netflix for Movie Theaters" ideology with VOD on all your devices. Gordon Scott Venters, President and CEO stated today.
Unfortunately yeah. Note holders are goofs. Could have been crazy here but they act like they need money 2 pay rent lol.
Thanks bro. Coming from one of the DD masters, means a lot.
lol right when I posted they joined
VNDM @ .0049, that's all the boogeymen I see. Waiting 4 word on signing.
Good morning CAYO and MVES's. American Film Market is winding up this week. Get some news out and the engines runnin.
16.6 million BTC in circulation... Imagine a publicly traded companies float being 16.6 million and being openly traded by the world.. Best part so few people actually know of it.. When this goes mainstream, as in everyday JOE trades and wants it... This will see 25k per sooner then most think.
That kind of investment is 2 kill 4. Totally agree with you my man.
No RS promised and great SS here. $ECMH looking great. This week should be greened out.
Great future here @ MVES. Vital information for everyone. I'm thinking MVES wants a move 2 OTCQB.
MVES recently acquired Emerging Media Corporation and EMC’s Commercial Grade Video on Demand Network. This proprietary B2B Video on Demand (VOD) technology allows MVES to stream films directly to theaters much like Netflix, Amazon Prime and Hulu do for in-home audiences.
To date, the distribution network has been installed at theaters spanning 35 states and boast a library of approximately 1,800 film titles. It is vital in the industry because it provides seamless point-to-point digital distribution and lowers costs across the whole distribution network.
The Acquisition includes a BigData Analytics to gauge consumer demand as well as match and deliver content for audiences (suggested videos or trending videos for example). This enables providers and exhibitors to be more effective and advanced in their distribution tactics and have greater direct contact and feedback from their audiences.
BigData is the most important aspect of the VOD platform because the data can enrich the customer experience. BigData, suggestion, and prediction technology are used in Youtube, Netflix, Amazon, and others so that next word predictions narrow down the search saving time for the customer. Predictive text is vital for customer retention and revenue stream as the data can be shared with the Company partners.
HALLANDALE BEACH, Fla., Nov. 01, 2017 (GLOBE NEWSWIRE) -- The Movie Studio, Inc. (OTC PINK:MVES) proudly announces exhibiting at the 2017 American Film Market in association with Cinema Arts Entertainment to present The Movie Studio's list of feature films in its film library for worldwide distribution and the solicitation of the release of its motion pictures for worldwide distribution including EXPOSURE currently on Amazon Prime in 80 million homes: https://www.amazon.com/Exposure-Corey-Feldman/dp/B075Y33KR6/ref=tmm_aiv_swatch_1?_encoding=UTF8&qid=&sr=, as well as the new release of "BAD ACTRESS," starring Colombian sensation "EXCELINA" and Michael Gibb, son of Barry Gibb from the world famous "Bee Gees." The company intends to aggregate new movies from other independent studios onto its newly acquired Emerging Pictures Theatrical Distribution on the platform.
The Company will be represented at the American Film Market November 1st -8th in Los Angeles, California to license worldwide distribution territories of its completed films, EXPOSURE & DANCING ON THE EDGE, EXOTIC BRIDE.
"We are excited about all our recent developments, and the parties' participation and our recent acquisitions with our business model as we continue to galvanize our strategy in the theatrical and worldwide motion picture distribution market," Gordon Scott Venters, the President & CEO, announced today.
The Movie Studio, Inc. is currently involved with substantial feature film projects, music videos, television shows and other intellectual properties.
Forbearance agreement is our judge and jury. They sign it and we are golden here. Should be getting word tomorrow I would think.
BTC @ $7600! Did $RMRK pick the best time ever.. Gotta release the kraken of PR's.
Closing bell means segue into crypto markets until opening bell rings . Crypto is 24-7, global market in the most literal sense. No more East Coast rules
.
On the mark Bala.. Final outcome here will be very profitable 4 buyers @ this level.
Hope so my man. I recall that post btw, great info it.
With the dilution stopping, might be a good sign something is in the works.
It has been hit hard last few days.. This week we should hear about the forbearance agreement. Float is still under 30m.
More and more I look into RCHA and HPGN connection, more I like here. This is from HPGN 10Q. Both Ben and Richard have quite the shares 4 HPGN. Richard has control of any matter that requires shareholder vote @HPGN. Like mergers etc. HPGN whole business seems 2 rely on the patent that Richard Chang assigned to HPGN.
On June 28, 2017, the Company executed an Asset Assignment Agreement (“Asset Assignment Agreement”) with Richard L. Chang Holding’s LLC (“Holdings LLC”), pursuant to which Holdings was issued 60,000,000 shares of the Company’s common stock and 2,000,000 restricted, non-convertible, non-dividend paying shares of the Company’s preferred stock with 1000 to 1 voting rights over shares of the Company’s common stock. In consideration of these share issuances, Holdings LLC has assigned to the Company all of its rights, title and interest in United States Utility Patent Application No. 62/420,177 filed on November 10, 2016, titled “ COMPOSITIONS AND METHODS OF USE OF PHORBOL ESTERS FOR THE TREATMENT OF PARKINSON’S DISEASE” and all related intellectual property, inventions and trade secrets, data, and clinical study results. Additionally, the Company issued 15,000,000 to Rich Pharmaceuticals, Inc. common shares for use of the clinical trial under an Investigational New Drug Application. Additionally, pursuant to the terms of the Asset Assignment Agreement, upon the Company receiving a minimum of $1,000,000 in equity financing, Holdings shall assign to the Company all of its rights, title and interest to United States Utility Patent Application No USPTO Application No. 15/385,862 filed on December 20, 2016, titled ” COMPOSITIONS AND METHODS OF USE OF PHORBOL ESTERS FOR THE TREATMENT OF STROKE” and all related intellectual property, inventions and trade secrets, data, and clinical study results . The Asset Assignment Agreement grants to Holdings LLC the right to require the Company to assign back to Holdings LLC the Patent Application and all related intellectual property in the event the Company does not raise a minimum of $1,000,000 in equity financing by June 28, 2018 . In the event that Holdings LLC exercises this right of reversion, the 2,000,000 shares of Preferred Stock issued to Holdings LLC shall be assigned to Apica Investments Limited or its assignees.
The issuance of Preferred Stock to our major shareholder provides it with voting control which may limit your ability and the ability of our other stockholders, whether acting alone or together, to propose or direct the management or overall direction of our Company. Our major shareholder has 2,000,000 shares of Preferred Stock which provides it with 1000 to 1 voting rights over shares of common stock. This ownership provides the shareholder with voting control over matters which require shareholder approval. This concentration of voting power could discourage or prevent a potential takeover of our Company that might otherwise result in an investor receiving a premium over the market price for his shares. If you acquire shares of our common stock, you may have no effective voice in the management of our Company. Such concentrated control of our Company may adversely affect the price of our common stock. Our principal stockholders may be able to control matters requiring approval by our stockholders, including the election of directors, mergers or other business combinations. Such concentrated control may also make it difficult for our stockholders to receive a premium for their shares of our common stock in the event we merge with a third party or enter into different transactions which require stockholder approval. These provisions could also limit the price that investors might be willing to pay in the future for shares of our common stock.
On July 8, 2017, the Company entered into a consulting agreement with Imagic, LLC (“Imagic”). Imagic, is wholly owned by Ben Chang, son of Director Richard L. Chang and Chief Executive Officer of Rich Pharmaceuticals, Inc. Upon the commencement of this engagement, the consultant or it’s designees were issued shares of the Company in the amount of 12,000,000 common shares. Imagic was also issued a warrant to acquire 10,000,000 shares of the Company at an exercise price of $0.25. At all times during the term of this agreement prior to the $5,000,000 financing date, except with respect to the “Excepted Issuances” (SEE NOTE 6), if the Company issues any shares of Company common stock, the consultant shall be granted additional shares of the Company’s common stock in an amount equal to 10.6% of the amount of the shares of Company common stock issued by the Company outside “Excepted issuances”.
Ya, news should come out with the dealings on the conversions next week. Maybe over the weekend but I doubt it.
Yes yes. AFM is going on @ this very moment.. Also the app, when done or news breaks, will be mega. So many catalysts about 2 break here.
“Vu-Me (vu.me) is The Movie Studio “APP” that we have always envisioned and when completed, could accelerate The Movie Studio content and business model with a unique platform currently not implemented by any other independent motion picture Company and create unique value propositions for on-line subscribers aligning an APP for Theatrical Releases and subsequent VOD releases, would be a “Netflix for Movie Theaters” ideology with VOD on all your devices. Gordon Scott Venters, President and CEO stated today.
Sure is looking that way. A lot of volume today.
Yeah. OTCQB who was trading @ .15+ this year.. Only thing happened is Irma. They sign and give us time 2 build back up.. Win win.
Grabbed 7s today in the AM.. Fresh start and good words from CEO.
there will be no reverse spilt. and we currently do not have any outstanding notes that we are aware of.
As part of the shift, Encompass Holdings is also pleased to announce its new president and Board of Director, Mark Miller. Mr. Miller has extensive experience in Real Estate Acquisitions, Real Estate Investment, Real Estate Development, and Construction. For the past 8 Years, Mr. Miller has been the active CEO of DDG Properties, LLC, a Real Estate Holdings Company.
"Our first priority and focus is to bring ECMH back to an active status in the State of Nevada. In addition, we believe that bringing the past due filings current with the OTC to achieve a Pink Current status is equally important," said Miller, president of Encompass Holdings, Inc.
Received an email back from company yesterday. Quick replies so far.. If the holders sign the forbearance agreement, we are golden here. Share structure is still great.
Thank you for your interest and support of Tiger Reef, Inc. (OTCQB: TGRR). It has been a very difficult period for both the Company and its employees and contractors.
In answer to your question, yes, any developments within the company – positive or negative – will be shared with the shareholder via a formal press release and/or SEC filings.
At the moment the Company is focused on getting its convertible debtholders into a Forbearance Agreement and to raise new funds to move forward with the Tiger Reef brand of ultra premium rums. When developments occur they will be shared with the investing community.
Volume just keeps churning.. Crazy if 13s fall today.